Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 619-020-1 | CAS number: 94361-06-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
- Ames: +S9 negative, -S9 negative, S. typhimurium: TA1535, TA1537, TA98, TA100 and E. coli WP2 uvrA pKM101 and WP2 pKM101, according to OECD TG 471, Sokolowski 2009
- In vitro gene mutation assay: +S9 negative, -S9 negative, Chinese hamster V79 cells, equivalent to OECD TG 476, Miltenburg 1995
- In vitro chromosome aberration test: +S9 negative, -S9 negative, Chinese hamster Ovary (CHO), equivalent to OECD TG 473, Murli 1985
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 10 Mar 2009 to 07 May 2009
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 1997
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- his- (S. typhimurium), trp- (E. coli)
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A pKM 101
- Species / strain / cell type:
- E. coli, other: WP2 pKM101
- Metabolic activation:
- with and without
- Metabolic activation system:
- Type and composition of metabolic activation system:
- Source of S9 : Phenobarbital/β-Naphthoflavone induced rat liver S9
- Method of preparation of S9 mix: The S9 is prepared from 8 - 12 weeks old male Wistar rats, weight approx. 220 - 320 g induced by applications of 80 mg/kg b.w. Phenobarbital i.p. and β- Naphthoflavone p.o. each on three consecutive days. The livers are prepared 24 hours after the last treatment. The S9 fractions are produced by dilution of the liver homogenate with a KCl solution (1+3) followed by centrifugation at 9000 g. Aliquots of the supernatant are frozen and stored in ampoules at -80 °C. Small numbers of the ampoules can be kept at -20 °C for up to one week. The protein concentration in the S9 preparation was 27.8 mg/mL in both experiments.
- Concentration or volume of S9 mix and S9 in the final culture medium: The amount of S9 supernatant was 10% v/v in the S9 mix. Cofactors are added to the S9 mix to reach the following concentrations in the S9 mix: 8mM MgCl2, 33 mM KCl, 5 mM Glucose-6-phosphate, 5 mM NADP in 100 mM sodium-ortho-phosphate-buffer, pH 7.4.
- Quality controls of S9: Each batch of S9 mix is routinely tested with 2-aminoanthracene as well as benzo(a)pyrene. - Test concentrations with justification for top dose:
- Pre-Experiment /Experiment I: 3; 10; 33; 100; 333; 1000; 2500; and 5000 µg/plate
Experiment II: 1, 3; 10; 33; 100; 333; 1000; 2500; and 5000 µg/plate - Vehicle / solvent:
- - Solvent used: DMSO
- Justification for choice of solvent: The solvent was chosen because of its solubility properties and its relative non-toxicity to the bacteria
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- methylmethanesulfonate
- other: 4-nitro-o-phenylene-diamine (4-NOPD), 2-aminoanthracene (2-AA)
- Details on test system and experimental conditions:
- PRE- EXPERIMENT FOR TOXICITY:
Eight concentrations were tested for toxicity and mutation induction with three plates each. The experimental conditions in this pre-experiment were the same as described below for the experiment I (plate incorporation test).
Toxicity of the test item results in a reduction in the number of spontaneous revertants or a clearing of the bacterial background lawn. The pre-experiment is reported as main experiment I, if the following criteria are met: Evaluable plates (>0 colonies) at five concentrations or more in all strains used.
EXPERIMENTAL PERFORMANCE:
For each strain and dose level including the controls, three plates were used.
The following materials were mixed in a test tube and poured onto the selective agar plates:
- 100 µL Test solution at each dose level, solvent (negative control) or reference mutagen solution (positive control),
- 500 µL S9 mix (for test with metabolic activation) or S9 mix substitution buffer (for test without metabolic activation),
- 100 µL Bacteria suspension (cf. test system, pre-culture of the strains),
- 2000 µLOverlay agar
In the pre-incubation assay 100 JL test solution solvent or positive control, 500 JL S9 mix / S9 mix substitution buffer and 100 µL bacterial suspension were mixed in a test tube and shaken at 37° C for 60 minutes. After pre-incubation 2.0 mL overlay agar (45° C) was added to each tube. The mixture was poured on selective agar plates. After solidification the plates were incubated upside down for at least 48 hours at 37°C in the
dark
DATA RECORDING:
The colonies were counted using the Petri Viewer Mk2 (Perceptive Instruments Ltd, Suffolk CB9 7BN, UK) with the software program Ames Study Manager. The counter was connected to an IBM AT compatible PC with printer to print out the individual values and the means from the plates for each concentration together with standard deviations and enhancement factors as compared to the spontaneous reversion rates (see tables of results). Due to reduced background growth the colonies were partly counted manually. - Evaluation criteria:
- ACCEPTABILITY OF THE ASSAY
The Salmonella typhimurium and Escherichia coli reverse mutation assay is considered acceptable if it meets the following criteria:
- Regular background growth in the negative and solvent control
- The spontaneous reversion rates in the negative and solvent control are in the range of historical data
- The positive control substances should produce a significant increase in mutant colony frequencies
EVALUATION OF THE RESULTS:
A test item is considered as a mutagen if a biologically relevant increase in the number of revertants exceeding the threshold of twice the colony count of the corresponding solvent control is observed. A dose dependent increase is considered biologically relevant if the threshold is exceeded at more than one concentration. An increase exceeding the threshold at only one concentration is judged as biologically relevant if reproduced in an independent second experiment. A dose dependent increase in the number of revertant colonies below the threshold is regarded as an indication of a mutagenic potential if reproduced in an independent second experiment. However, whenever the colony counts remain within the historical range of negative and solvent controls such an increase is not considered biologically relevant. - Statistics:
- According to the OECD guideline 471, a statistical analysis of the data is not mandatory
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli, other: WP2 uvrA pKM101 and WP2 pKM101
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation of the test item: Precipitation of the test item was observed in the test tubes in the presence of metabolic activation in both experiments. No visible precipitation was observed on the incubated agar plates with and without metabolic activation in both experiments.
STUDY RESULTS:
- Signs of toxicity: Toxic effects, evident as a reduction in the number of revertants (below the indication factor of 0.5), were observed at the higher concentrations with and without metabolic activation in both experiments shown in table 1 in 'Any other information on results incl. tables'.
- Mean number of revertant colonies per plate: No substantial increase in revertant colony numbers of any of the six tester strains was observed following treatment with the test substance at any dose level, neither in the presence nor absence of metabolic activation (S9 mix). There was also no tendency of higher mutation rates with increasing concentrations in the range below the generally acknowledged border of biological relevance. - Conclusions:
- The test substance is considered to be non-mutagenic in this Salmonella typhimurium and Escherichia coli reverse mutation assay.
- Executive summary:
This study was performed to investigate the potential of the test substance to induce gene mutations in the plate incorporation test (experiment I) and the pre-incubation test (experiment II) using the Salmonella typhimurium strains TA 1535, TA 1537, TA 98, and TA 100, and the Escherichia coli strains WP2 uvrA pKM101 and WP2 pKM101, according to GLP principles and OECD TG 471.
Results showed that reduced background growth was observed with and without metabolic activation from 1000 up to 5000 µg/plate in experiment I, and from 333 up to 5000 µg/plate in experiment II. Toxic effects, evident as a reduction in the number of revertants (below the indication factor of 0.5), were observed at the higher concentrations with and without metabolic activation in both experiments. No substantial increase in revertant colony numbers of any of the six tester strains was observed following treatment with the test substance at any dose level, neither in the presence nor absence of metabolic activation (S9 mix). There was also no tendency of higher mutation rates with increasing concentrations in the range below the generally acknowledged border of biological relevance. Precipitation of the substance was observed in the test tubes in the presence of metabolic activation in both experiments. No visible precipitation was observed on the incubated agar plates with and without metabolic activation in both experiments. Appropriate reference mutagens (sodium azide, 4-nitro-o-phenylene-diamine, 2-aminoanthracene and methyl methane sulfonate)were used as positive controls. They showed a distinct increase of induced revertant colonies.
In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used. Therefore, the test substance is considered to be non-mutagenic in this Salmonella typhimurium and Escherichia coli reverse mutation assay.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 17 Oct 1990 to 8 Nov 1990
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosomal Aberration Test)
- Version / remarks:
- 1997
- Deviations:
- yes
- Remarks:
- Cells were treated for an extended period of time in the absence of S9 treatment.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
- Version / remarks:
- 2000
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EPA OPPTS 870.5375 - In vitro Mammalian Chromosome Aberration Test
- Version / remarks:
- 1998
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Details on mammalian cell type (if applicable):
- CELLS USED:
The cells have since been recloned to maintain karyotypic stability. This cell line has an average cycle time of 12 to 14 hours with a modal chromosome number of 21.
MEDIA USED:
The CHO cells were grown in McCoy's 5a culture medium which was supplemented with 10% fetal calf serum (FCS), 1% L-glutamine, and 1% penicillin and streptomycin, at about 37°C, in an atmosphere of about 5% CO2 in air. - Cytokinesis block (if used):
- 0.1 mg/mL colcemid
- Metabolic activation:
- with and without
- Metabolic activation system:
- Type and composition of metabolic activation system:
- Source of S9 : The S9 fraction was derived from the liver of male Sprague-Dawley rats which had been previously treated with Aroclor 1254. - Test concentrations with justification for top dose:
- - Range finding assay: up to 2050 μg/ml
- The mutagenicity test without S9: 60.1, 100, 150, 200 μg/mL
- The mutagenicity test with S9: 45, 59.9, 99.9 and 150 μg/mL - Vehicle / solvent:
- - Solvent used: DMSO
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- mitomycin C
- Details on test system and experimental conditions:
- METHOD OF TREATMENT/ EXPOSURE:
Single cultures were used for the negative control, solvent control, and the positive controls. In the test without metabolic activation. One day after culture initiation, the cultures were treated with the test substance. 2.5 hours before harvest culture medium was exchanged and supplemented with 0.1 mg/mL colcemid. In the test with metabolic activation cultures were initiated by seeding approximately 1.5 x 10^6 cells/75 cm^2 culture flasks into 10 mL of medium. One day thereafter the cultures were incubated for two hours in the presence of the test substance and the S9-mix in McCoy’s 5a medium without foetal calf serum. After exposure the cells were washed and reefed with complete McCoy’s 5a medium. Incubation was continued for an additional 7.84 hours with 0.1 mg/mL colcemid present during the last 2.5 hours of incubation. The metaphase cells were then harvested and prepared for cytogenetic analysis. Chromosomal aberrations were analysed for the cultures treated at the four highest doses from which results could be obtained. Whenever possible one hundred well spread metaphase figures with 21 + 2 centromeres per culture in the negative control and in the treated groups were examined for chromosome aberrations.
TREATMENT AND HARVEST SCHEDULE:
Monolayer cultures were treated for 17.25 hours in the absence of S9 and harvested for slide preparation 20 hours after beginning of treatment. In the presence of S9 treatment was for 2 hours. Cells were harvested 10 hours after beginning of treatment. - Evaluation criteria:
- The following factors were taken into account in the evaluation of the chromosomal aberrations data:
- The overall chromosomal aberration frequencies.
- The percentage of cells with any aberrations.
- The percentage of cells with more than one aberration.
- Any evidence for increasing amounts of damage with increasing dose, i.e., a positive dose response - Statistics:
- Statistical analysis employed the Fisher's Exact Test with an adjustment for multiple comparisons (Sokal and Rohlf, 1981) to compare the percentage of cells with aberrations in each treatment group with the results from the pooled solvent and negative controls (the solvent and negative controls were statistically evaluated for similarity prior to the pooled evaluation). Test article significance was established where p<0.01. All factors as stated previously were taken into account and the final evaluation of the test article was based upon scientific judgement.
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- The range-finding assay in the absence of S9 resulted in complete toxicity at 683 µg/mL and above. At the concentration of 205 µg/mL a severe cell cycle delay was noted together with cytotoxicity and delayed cell cycle progression was also noted at 68.3 µg/mL. For the chromosome aberration test a 20 hour harvest time and concentrations from 60 to 500 µg/mL were selected. In the presence of S9 complete toxicity was seen at 205 µg/mL and above. No evidence of cell cycle delay and cytotoxicity was noted at the lower concentrations. A 10 hours harvest time and concentrations from 15 to 200 µg/mL were selected for the chromosome aberration test. In the chromosome aberration test without S9 cultures treated at 300 to 500 µg/mL could not be analysed due to toxicity. Moderate to slight cytotoxicity was also seen at 200 and 150 µg/ml. No significant increase in cells with chromosomal aberrations was observed at the concentrations analysed. Due to cytotoxicity the concentration of 200 µg/mL could not be analysed in the experiment with metabolic activation. Less severe signs of cytotoxicity were also evident at concentrations below 200 µg/mL. There was a 15% reduction in the monolayer at 150 µg/mL, floating debris and a slight reduction in visible mitotic cells were observed in cultures dosed with 100 µg/mL and 60 µg/mL. There was also no significant increase in cells with chromosomal aberrations observed at the concentrations analysed in this part of the experiment.
- Conclusions:
- The test substance was considered negative for inducing chromosomal aberrations in Chinese hamster ovary cells under both the metabolic activation and non-activation conditions of this assay.
- Executive summary:
The objective of this in vitro assay was to evaluate the ability of the test substance to induce chromosomal aberrations in Chinese hamster ovary (CHO) cells with and without metabolic activation, according to GLP principles and OECD TG 473. The test substance was dissolved in dimethyl sulfoxide at a stock concentration of 205 mg/mL. Concentrations of 0.0683 µg/mL to 2050 µg/mL in a half-log series were tested in range-finding assays with and without metabolic activation. The following concentrations were tested in the mutagenicity test: 60.1, 100, 150, 200 µg/mL (without metabolic activation) and 45, 59.9, 99.9 and 150 µg/mL (with metabolic activation). Monolayer cultures were treated for 17.25 hours in the absence of S9 and harvested for slide preparation 20 hours after beginning of treatment. In the presence of S9 treatment was for 2 hours.
Results showed that complete cytotoxicity was observed in the cultures dosed with 683 and 2050 µg/mL, and severe cell cycle delay was evident in the culture dosed with 205 µg/mL, with cell cycle delay persisting in the culture dosed with 68.3 µg/mL in the range- finding assay without activation. Complete cytotoxicity was observed in the cultures dosed with 205, 683, and 2050 µg/mL, and no cell cycle delay was evident in the cultures analysed in the range- finding assay with activation. Based on these results, replicate cultures of CHO cells were incubated with 60.1 µg/mL to 500 µg/mL of the test article solution in a 20 hour non-activation aberrations assay, and with 15.0 µg/mL to 200 µg/mL in a 10 hour aberrations assay with metabolic activation. No significant increase in cells with chromosomal aberrations was observed at the concentrations analysed. The sensitivity of the cell culture for induction of chromosomal aberrations was shown by the increased frequency of aberrations in the cells exposed to the positive control agents (mitomycin C and cyclophosphamide).
In conclusion, the test substance was considered negative for inducing chromosomal aberrations in Chinese hamster ovary cells under both non-activation and activation conditions of this assay.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 7 Jan 1985 to 30 Jan 1985
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- 2000
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- 1997
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EPA OPPTS 870.5300 - In vitro Mammalian Cell Gene Mutation Test
- Version / remarks:
- 1998
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian cell gene mutation test using the Hprt and xprt genes
- Target gene:
- HPRT locus
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- CELLS USED
- Suitability of cells: The V79 cell line has been used for many years in in vitro experiments with success, due to the high proliferation rate (doubling time 12-16 h in stock cultures) and high plating efficiency of untreated cells (70-90 %)
For cell lines:
- Cell cycle length, doubling time or proliferation index : doubling time 12-16 h in stock cultures
- Modal number of chromosomes: 22
- Periodically checked for karyotype stability: yes, stable
MEDIA USED
- Type and composition of media, CO2 concentration, humidity level, temperature, if applicable: Two days old logarithmically growing stock cultures more than 50 % confluent were trypsinised and a single cell suspension was prepared. The trypsin concentration for all subculturing steps was 0.2 % in Ca-Mg-free salt solution. The Ca-Mg-free salt solution was composed as follows (per litre): NaCl 8000 mg; KCl 400 mg; glucose 1000 mg; NaHCO3 350 mg. The "saline G" was composed
(per litre): NaCl 8000 mg; KCl 400 mg; glucose 1100 mg; Na2HPO4 · 7H2O 290 mg; KH2PO 4 150 mg. The cells were incubated at 37°C - Metabolic activation:
- with and without
- Metabolic activation system:
- Type and composition of metabolic activation system:
- Source of S9 : The S9 liver microsomal fraction is obtained from the liver of 8-12 weeks old male Wistar rats, strain CFHB (weight ca. 150 -200 g) which had been given a single i.p. injection of 500 mg/kg bw Aroclor 1254 in olive oil 5 days previously.
- Method of preparation of S9 mix : The livers of 5 animals are removed, washed in 150 mM KCl and homogenised. The homogenate, diluted 1:3 in KCl is centrifuged cold at 9000 g for 10 minutes. The supernatant which contains microsomes is frozen in ampoules of 2 or 5 mL and stored in liquid nitrogen.
- Concentration or volume of S9 mix and S9 in the final culture medium: Before the experiment an appropriate quantity of S9 supernatant is thawed and mixed with S9 cofactor solution to result in a final protein concentration of 0.3 mg/mL in the cultures. The concentration in the S9 preparation is between 30 and 45 mg/mL. The composition of the cofactor solution is concentrated to yield the following concentrations in the S9 mix: 8 mM MgCl 2; 33 mM KCl; 5 mM glucose-6-phosphate; 5 mM NADP; 100 mM sodium-ortho-phosphate-buffer, pH 7.4. - Test concentrations with justification for top dose:
- 20, 50, 100 or 200 μg/mL of the test substance
- Vehicle / solvent:
- - Solvent used: Dimethyl sulfoxide (DMSO).
- Percentage of solvent in the final culture medium: 1% - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9,10-dimethylbenzanthracene
- ethylmethanesulphonate
- Details on test system and experimental conditions:
- METHOD OF TREATMENT/ EXPOSURE:
24 h after subculturing the medium was replaced with medium containing 2 % FCS and the test substance, without S9 mix and with 20 µL/mL S9 mix. After 4 h this medium was replaced with normal medium after rinsing with "saline G". Treatment was performed with each 4 concentrations of the test substance without and with S9 mix. The toxicity of the test substance was determined in a pre-experiment by establishing the concentration related plating efficiency. According to these data the concentration range was chosen.
Treatment scheme:
Day 1: Subculturing of a log-phase culture:
a) About 400 cells in 5 mL medium/25 cm2 plastic flask for plating efficiency; in duplicate per experimental point,
b) 1x10^6 cells in 30 mL medium/175 cm2 plastic flask for the mutagenicity test, 1 flask per experimental point
Day 2: Treatment of a) and b);
Day 5: Subculturing of b) in 175 cm2 plastic flasks
Day 8: Fixation and staining of colonies in: a) flasks = plating efficiency and dose relationship
Day 9: Subculturing of b) in five 80 cm2 plastic flasks containing selective medium: mutant selection (about 6x10^5 cells/flask); subculturing of b) in two 25 cm2 flasks for plating efficiency (about 500 cells/flask)
Day 16: Fixation and staining of colonies in b) - derived flasks seeded on day 9
All incubations are done at 37°C. - Evaluation criteria:
- The evaluation of the results was performed as follows:
- The test substance is classified as mutagenic if it induces for at least one of the test substance concentrations reproducibly a mutation frequency that is three times higher than the spontaneous mutant frequency in this experiment
- The test substance is classified as mutagenic if there is a reproducible concentration related increase in the mutant frequency. Such evaluation may be considered independently of the enhancement factor for the induced mutants. - Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- Concentrations of the test substance higher than 200 µg/mL produced precipitations. Up to 200 µg/mL the test substance did not induce a marked cell mortality. In two independently performed experiments no mutagenic activity could be detected under the experimental conditions described in the test report
- Conclusions:
- It is concluded that under the conditions of the experiments the test substance is not mutagenic in V79 Chinese hamster cells in vitro.
- Executive summary:
The test substance was assessed for its mutagenic potential in the mammalian HGPRT system using Chinese hamster cell line V79, according to GLP principles and OECD TG 476. The cells were exposed to the test substance both without and with metabolic activation for four hours at concentrations of 20, 50, 100, and 200 µg/mL without S9 mix and with S9 mix. Concentrations of the test substance higher than 200 µg/mL produced precipitations.
Results showed that up to 200 µg/mL the test substance did not induce a marked cell mortality. In two independently performed experiments no mutagenic activity could be detected under the experimental conditions. The clearly enhanced mutation rates after treatment with the positive control substances ethyl-methane sulfonate and 9,10- dimethyl-1,2-benzanthracene demonstrated the sensitivity of the test system.Therefore, it can be stated that a mutagenic activity of the test substance could not be detected in the in vitro gene mutation test, HGPRT test, using cells of Chinese hamster cell line V79.
Referenceopen allclose all
Table 1. Toxic effects, evident as a reduction in the number of revertants
Strain |
Experiment I |
Experiment II |
||
|
without S9 mix |
with S9 mix |
without S9 mix |
with S9 mix |
TA 1535 |
2500, 5000 |
2500, 5000 |
2500, 5000 |
1000 - 5000 |
TA 1537 |
1000 - 5000 |
2500, 5000 |
1000 - 5000 |
2500, 5000 |
TA 98 |
2500, 5000 |
2500, 5000 |
1000 - 5000 |
1000 - 5000 |
TA 100 |
2500, 5000 |
2500, 5000 |
2500, 5000 |
2500, 5000 |
WP2 uvrA pKM101 |
2500, 5000 |
2500, 5000 |
2500, 5000 |
1000 - 5000 |
WP2 pKM101 |
2500, 5000 |
2500, 5000 |
1000 - 5000 |
1000 - 5000 |
Table 1. Chromosome aberrations in CHO cells in vitro (2nd study) Experiment without S9-mix
Concentration (µg/mL) |
% cells with aberrations (excl. gaps) |
simple aberrations (breaks, fragments) |
complex aberrations (chr and ctd exchanges) |
Others |
0 |
0.5 |
1 |
|
|
60.1 |
1.5 |
1 |
2 |
|
100 |
0.5 |
|
1 |
|
150 |
1.0 |
|
2 |
|
200 MMC |
0.5 32* |
1 1 |
10 |
Experiment with S9-mix
Concentration (µg/mL) |
% cells with aberrations (excl. gaps) |
simple aberrations (breaks, fragments) |
complex aberrations (chr and ctd exchanges) |
Others |
0 |
0.0 |
|
|
|
45.0 |
0.5 |
|
1 |
|
59.9 |
2.0 |
|
4 |
|
99.9 |
0.0 |
|
|
|
150 CP |
1.0 44* |
1 6 |
2 9 |
Table 1. Summary of results of gene mutation test in V79 cells
|
without S9 |
with S9 |
||||||
plating efficiency after treatm. |
plating efficiency after express. |
mutants per plate |
mutants per 10^6 cells |
plating efficiency after treatm. |
plating efficiency after express. |
mutants per plate |
mutants per 10^6 cells |
|
1st experiment |
||||||||
DMSO Pos. control 20 µg/mL 50 µg/mL 100 µg/mL 200 µg/mL |
98 92 101 95 95 86 |
86 82 88 103 101 97 |
28.8 194.3 19.2 21.4 27.0 12.2 |
70.7 428.6 49.8 45.2 48.8 24.0 |
97 56 92 90 96 86 |
84 94 88 97 100 95 |
7.6 52.4 9.0 18.0 14.0 13.8 |
27.9 154.8 23.2 38.2 30.7 32.2 |
2nd experiment |
||||||||
DMSO Pos. control 20 µg/mL 50 µg/mL 100 µg/mL 200 µg/mL |
101 89 95 105 100 83 |
78 76 86 83 99 87 |
7.2 112.8 16.2 12.2 9.4 13.0 |
24.7 394.2 54.4 38.2 23.7 39.2 |
91 25 96 94 94 75 |
83 102 93 85 85 104 |
14.6 49.2 11.4 9.4 9.6 12.4 |
43.8 93.5 31.7 21.3 29.4 27.7 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
- In vivo micronucleus test in mouse, negative, equivalent to OECD TG 474, Taalman 1985
Link to relevant study records
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 3 Dec 1984 to 19 Dec 1984
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- 1997
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- 2000
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EPA OPPTS 870.5395 (In Vivo Mammalian Cytogenetics Tests: Erythrocyte Micronucleus Assay)
- Version / remarks:
- 1998
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian erythrocyte micronucleus test
- Species:
- mouse
- Strain:
- Swiss
- Remarks:
- random
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: not reported
- Housing: Animals were group-housed up to 20 mice per cage
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: At least 5 days
IN-LIFE DATES: 3 Dec 1984 to 19 Dec 1984 - Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle used: DMSO
- Frequency of treatment:
- Single dose
- Post exposure period:
- Test group: 24, 48 and 72 hours.
Control animals: 24 hours - Dose / conc.:
- 16.7 mg/kg diet
- Remarks:
- Low dose
- Dose / conc.:
- 55.7 mg/kg diet
- Remarks:
- Mid dose
- Dose / conc.:
- 167 mg/kg diet
- Remarks:
- High dose
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- - Positive control: Cyclophosphamide (CP)
- Route of administration: intraperitoneal injection
- Doses: 100 mg/kg - Tissues and cell types examined:
- Bone marrow, Polychromatic erythrocytes (PCEs) and the number of mature erythrocytes (RBCs)
- Details of tissue and slide preparation:
- BONE MARROW EXTRACTION:
Animals were killed with CO2 or by cervical dislocation and the adhering soft tissue and epiphyses of both tibiae were removed. The marrow was flushed from the bone and transferred to centrifuge tubes containing 3 mL fetal calf serum (one tube for each animal).
DETAILS OF SLIDE PREPARATION:
Following centrifugation to pellet the tissue, the supernatant was drawn off, the cells resuspended in a drop of serum, and the suspension spread on slides and air-dried. The slides were then fixed in methanol, stained in May-Gruenwald solution followed by Giemsa, and rinsed in deionized water (Schmid, 1975).
METHOD OF ANALYSIS:
One thousand PCEs per animal were scored. The frequency of micronucleated cells was expressed as percent micronucleated cells based on the total PCEs present in the scored optic field. The frequency of PCEs versus mature RBCs was determined by scoring the number of mature erythrocytes (RBCs) observed in the optic fields while scoring the first 1000 PCEs for micronuclei. For control of bias, all slides were coded prior to scoring. - Evaluation criteria:
- The criteria for the identification of micronuclei were those of Schmid (1976). Micronuclei were darkly stained and generally round, although almond and ring-shaped micronuclei occasionally occur. Micronuclei had sharp borders and were generally between 1/20 and 1/5 the size of the PCE. The unit of scoring was the micronucleated cell, not the micronucleus; thus the occasional cell with more than one micronucleus was counted as one micronucleated PCE, not two (or more) micronuclei. The staining procedure permitted the differentiation by colour of polychromatic and normochromatic erythrocytes (bluish-grey and red, respectively).
- Statistics:
- Two-tailed student's t-test
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Animals exposed to test substance showed no significant increase in micronucleus frequency at any dose level, kill-time or sex. In addition no increase in the numbers of micronuclei was observed when the data for both sexes were pooled. The positive control, cyclophosphamide, induced a large and statistically significant increase in the frequencies of micronuclei (p ≤ 0.02 for males, p ≤ 0.01 females).
- Conclusions:
- The test substance did not induce any significant increase in micronucleus frequencies in bone marrow polychromatic erythrocytes of the mouse. Therefore, the test substance was considered inactive under the conditions of this assay
- Executive summary:
The test substance was evaluated for its ability to induce micronuclei in polychromatic erythrocytes (PCE’s) of male and female Swiss mouse bone marrow in a study following GLP principles and performed similar to OECD TG 474. Dose selection was based upon the LD50 (200 mg/kg for male mice and 218 mg/kg for female mice), using 80% of the combined LD50 for both sexes. Groups of 5 animals per sex per dose were received a single dose of 167.0, 55.7 and 16.7 mg/kg bw via oral gavage. The test substance was dissolved in Dimethylsulfoxide (DMSO). The positive control received an intraperitoneal injection of Cyclophosphamide (CP) at 100 mg/kg. Groups of animals were killed 24, 48 and 72 hours after administration of the test substance, the vehicle control and the positive control.
Results showed that animals exposed to the test substance showed no significant increase in micronucleus frequency at any dose level, kill time or sex. Also, no elevation of the numbers of micronuclei was observed if the data for the sexes are pooled. The positive control compound, cyclophosphamide (CP), induced large and statistically significant increases in the frequencies of micronuclei (p 0.02 ≤ males, p ≤ 0.01 females).
The test substance did not induce any significant increase in micronucleus frequencies in bone marrow polychromatic erythrocytes of the mouse. The test substance showed no mutagenicity under the conditions of this assay.
Reference
Table 1. Mean percentage (±SD) of micronucleated PCEs in mouse bone marrow
Test substance (concentration) |
Sex |
24 hours |
48 hours |
72 hours |
167 mg/kg
|
Males Females Mean |
0.32 ± 0.12 0.10 ± 0.06 0.21 ± 0.07
|
0.28 ± 0.11 0.06 ± 0.05 0.16 ± 0.06
|
0.40 ± 0.40 0.18 ± 0.08 0.24 ± 0.11
|
55.7 mg/kg
|
Males Females Mean
|
0.30 ± 0.14 0.16 ± 0.05 0.23 ± 0.07
|
0.16 ± 0.11 0.06 ± 0.02 0.11 ± 0.06
|
0.25 ± 0.07 0.10 ± 0.00 0.17 ± 0.04
|
16.7 mg/kg
|
Males Females Mean
|
0.14 ± 0.05 0.26 ± 0.14 0.20 ± 0.07
|
0.44 ± 0.20 0.26 ± 0.14 0.35 ± 0.12 |
0.24 ± 0.14 0.18 ± 0.04 0.21 ± 0.07 |
Negative control Vehicle (DMSO) |
Males Females Mean |
0.10 ± 0.05 0.34 ± 0.06 0.22 ± 0.05 |
|
|
Positive control Cyclophosphamide |
Males Females Mean |
1.94 ± 0.41* |
|
|
*) p ≤ 0.02 **) p ≤ 0.01
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
All available data was assessed and the studies representing the worst-case effects were included as key studies. Other studies are included as supporting information. The key study is considered to be worst-case and was selected for the CSA. For in vitro genetic toxicity, three key studies and six supporting studies are available. For in vivo genetic toxicity, one key study and two supporting studies are available.
In vitro genetic toxicity
The key study (Sokolowski 2009) was performed to investigate the potential of the test substance to induce gene mutations in the plate incorporation test (experiment I) and the pre-incubation test (experiment II) using the Salmonella typhimurium strains TA 1535, TA 1537, TA 98, and TA 100, and the Escherichia coli strains WP2 uvrA pKM101 and WP2 pKM101, according to GLP principles and OECD TG 471.
Results showed that reduced background growth was observed with and without metabolic activation from 1000 up to 5000 µg/plate in experiment I, and from 333 up to 5000 µg/plate in experiment II. Toxic effects, evident as a reduction in the number of revertants (below the indication factor of 0.5), were observed at the higher concentrations with and without metabolic activation in both experiments. No substantial increase in revertant colony numbers of any of the six tester strains was observed following treatment with the test substance at any dose level, neither in the presence nor absence of metabolic activation (S9 mix). There was also no tendency of higher mutation rates with increasing concentrations in the range below the generally acknowledged border of biological relevance. Precipitation of the substance was observed in the test tubes in the presence of metabolic activation in both experiments. No visible precipitation was observed on the incubated agar plates with and without metabolic activation in both experiments. Appropriate reference mutagens (sodium azide, 4-nitro-o-phenylene-diamine, 2-aminoanthracene and methyl methane sulfonate)were used as positive controls. They showed a distinct increase of induced revertant colonies.
In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used. Therefore, the test substance is considered to be non-mutagenic in this Salmonella typhimurium and Escherichia coli reverse mutation assay.
In the key study (Miltenburger 1985), the test substance was assessed for its mutagenic potential in the mammalian HGPRT system using Chinese hamster cell line V79, according to GLP principles and OECD TG 476. The cells were exposed to the test substance both without and with metabolic activation for four hours at concentrations of 20; 50; 100; and 200 µg/mL without S9 mix and with S9 mix. Concentrations of the test substance higher than 200 µg/ml produced precipitations.
Results showed that up to 200 µg/mL the test substance did not induce a marked cell mortality. In two independently performed experiments no mutagenic activity could be detected under the experimental conditions. The clearly enhanced mutation rates after treatment with the positive control substances ethyl-methane sulfonate and 9,10- dimethyl-l,2-benzanthracene demonstrated the sensitivity of the test system.
Therefore, it can be stated that a mutagenic activity of the test substance could not be detected in the in vitro gene mutation test, HGPRT test, using cells of Chinese hamster cell line V79.
In the key study (Murli 1985), the objective of this in vitro assay was to evaluate the ability of the test substance to induce chromosomal aberrations in Chinese hamster ovary (CHO) cells with and without metabolic activation, according to GLP principles and OECD TG 473. The test substance was dissolved in dimethyl sulfoxide at a stock concentration of 205 mg/mL. Concentrations of 0.0683 µg/mL to 2050 µg/mL in a half-log series were tested in range-finding assays with and without metabolic activation. The following concentrations were tested in the mutagenicity test: 60.1, 100, 150, 200 µg/mL (without metabolic activation) and 45, 59.9, 99.9 and 150 µg/mL (with metabolic activation). Monolayer cultures were treated for 17.25 hours in the absence of S9 and harvested for slide preparation 20 hours after beginning of treatment. In the presence of S9 treatment was for 2 hours.
Results showed that complete cytotoxicity was observed in the cultures dosed with 683 and 2050 µg/mL, and severe cell cycle delay was evident in the culture dosed with 205 µg/mL, with cell cycle delay persisting in the culture dosed with 68.3 µg/mL in the range- finding assay without activation. Complete cytotoxicity was observed in the cultures dosed with 205, 683, and 2050 µg/mL, and no cell cycle delay was evident in the cultures analysed in the range- finding assay with activation. Based on these results, replicate cultures of CHO cells were incubated with 60.1 µg/mL to 500 µg/mL of the test article solution in a 20 hour non-activation aberrations assay, and with 15.0 µg/mL to 200 µg/mL in a 10 hour aberrations assay with metabolic activation. No significant increase in cells with chromosomal aberrations was observed at the concentrations analysed. The sensitivity of the cell culture for induction of chromosomal aberrations was shown by the increased frequency of aberrations in the cells exposed to the positive control agents (mitomycin C and cyclophosphamide).
In conclusion, the test substance was considered negative for inducing chromosomal aberrations in Chinese hamster ovary cells under both non-activation and activation conditions of this assay.
All six of the supporting studies support the findings of the key studies that the test substance is negative for in vitro genetic toxicity. One of those studies was an Ames test (Hoorn 1986), one was a mutagenicity test in yeast cells (Hoorn 1985), two were chromosome aberration tests (Enninga 1995; Saigo 1995), another was a unscheduled DNA synthesis test (Curren 1986), and the final study was a transformation study (Miltenburger 1985).
In vivo genetic toxicity
In the key study (Taalman 1985), the test substance was evaluated for its ability to induce micronuclei in polychromatic erythrocytes (PCE’s) of male and female Swiss mouse bone marrow in a study following GLP principles and performed similar to OECD TG 474. Dose selection was based upon the LD50 (200 mg/kg for male mice and 218 mg/kg for female mice), using 80% of the combined LD50 for both sexes. Groups of 5 animals per sex per dose were received a single dose of 167.0, 55.7 and 16.7 mg/kg bw via oral gavage. The test substance was dissolved in Dimethylsulfoxide (DMSO). The positive control received an intraperitoneal injection of Cyclophosphamide (CP) at 100 mg/kg. Groups of animals were killed 24, 48 and 72 hours after administration of the test substance, the vehicle control and the positive control.
Results showed that animals exposed to the test substance showed no significant increase in micronucleus frequency at any dose level, kill time or sex. Also, no elevation of the numbers of micronuclei was observed if the data for the sexes are pooled. The positive control compound, cyclophosphamide (CP), induced large and statistically significant increases in the frequencies of micronuclei (p 0.02 ≤ males, p ≤ 0.01 females).
The test substance did not induce any significant increase in micronucleus frequencies in bone marrow polychromatic erythrocytes of the mouse. The test substance showed no mutagenicity under the conditions of this assay.
Two supporting studies are available which support the findings of the key study that the test substance is negative for in vivo genetic toxicity. One of the studies was a chromosomal aberration test in mice (Ogorek 2000) and the other was a dominant lethal assay in rats (Putman 1991).
Justification for classification or non-classification
Based on the available data classification for genetic toxicity is not warranted in accordance with EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.